Varian Medical Systems (VAR) Given Daily Coverage Optimism Score of 0.09
Media stories about Varian Medical Systems (NYSE:VAR) have been trending somewhat positive on Wednesday, Accern reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Varian Medical Systems earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 46.074189801276 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news articles that may have impacted Accern Sentiment’s analysis:
- Kolleen T. Kennedy Sells 1,088 Shares of Varian Medical Systems, Inc. (VAR) Stock (americanbankingnews.com)
- Varian Medical Systems, Inc. (VAR) Investment Up in Latest Report from Fairpointe Capital LLC – First News 24 (firstnewspaper24.com)
- Is Varian Medical Systems Inc (VAR) Headed For a Near-Term Reversal? – FLBC News (flbcnews.com)
- Fairpointe Capital LLC Buys Hormel Foods Corp, Akamai Technologies Inc, Mattel Inc, Sells Varian Medical Systems … – GuruFocus.com (gurufocus.com)
- Varian Medical Systems: Better Aligned, More Focused – Market Realist (marketrealist.com)
Varian Medical Systems (VAR) traded up 0.49% on Wednesday, hitting $99.71. The stock had a trading volume of 742,650 shares. Varian Medical Systems has a 1-year low of $75.20 and a 1-year high of $107.08. The stock’s 50-day moving average is $101.28 and its 200 day moving average is $93.94. The firm has a market capitalization of $9.15 billion, a price-to-earnings ratio of 32.82 and a beta of 0.61.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company had revenue of $662.40 million for the quarter, compared to analysts’ expectations of $663.86 million. During the same quarter in the prior year, the firm earned $1.00 earnings per share. Varian Medical Systems’s revenue was up 3.0% compared to the same quarter last year. On average, equities research analysts predict that Varian Medical Systems will post $3.93 earnings per share for the current fiscal year.
A number of equities research analysts have recently weighed in on the company. BidaskClub lowered Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Off Wall Street assumed coverage on Varian Medical Systems in a research report on Monday, April 24th. They issued a “sell” rating on the stock. Zacks Investment Research lowered Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, April 28th. Citigroup Inc. upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating in a research report on Monday, May 15th. Finally, Jefferies Group LLC reiterated a “buy” rating on shares of Varian Medical Systems in a research report on Thursday, May 11th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $96.28.
In related news, SVP John W. Kuo sold 19,819 shares of the stock in a transaction that occurred on Wednesday, May 31st. The stock was sold at an average price of $99.67, for a total value of $1,975,359.73. Following the transaction, the senior vice president now owns 47,180 shares of the company’s stock, valued at $4,702,430.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Mark R. Laret sold 1,428 shares of the stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $103.47, for a total value of $147,755.16. Following the completion of the transaction, the director now directly owns 3,289 shares in the company, valued at approximately $340,312.83. The disclosure for this sale can be found here. In the last three months, insiders sold 159,372 shares of company stock worth $16,128,658. 0.91% of the stock is owned by insiders.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.